Challenges and perspective of cancer patients during the COVID-19 pandemic and the Lebanese financial crisis

Tailoring radiation therapy in the 21st century

Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer patients

Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL

International Society of Paediatric Surgical Oncology (IPSO) surgical practice guidelines

PET scanning in patients with classical Hodgkin lymphoma outside of Europe and North America

Update: Cabozantinib plus nivolumab demonstrates continued survival benefit in aRCC

KEYNOTE 564 update: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma

ASCO GU 2022: What to watch out for in renal

Maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma

First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study.

Durvalumab with olapirib shows no PFS improvement for platinum-ineligible bladder cancer